Cargando…
Autologous cell-based therapy for treatment of large bone defects: from bench to bedside
OBJECTIVES: Reconstruction of long segmental bone defects is demanding for patients and surgeons, and associated with long-term treatment periods and substantial complication rates in addition to high costs. While defects up to 4–5 cm length might be filled up with autologous bone graft, heterologou...
Autores principales: | Verboket, R., Leiblein, M., Seebach, C., Nau, C., Janko, M., Bellen, M., Bönig, H., Henrich, D., Marzi, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182650/ https://www.ncbi.nlm.nih.gov/pubmed/29352347 http://dx.doi.org/10.1007/s00068-018-0906-y |
Ejemplares similares
-
Safety and feasibility of cell-based therapy of autologous bone marrow-derived mononuclear cells in plate-stabilized proximal humeral fractures in humans
por: Seebach, Caroline, et al.
Publicado: (2016) -
First Human Leucocyte Antigen (HLA) Response and Safety Evaluation of Fibrous Demineralized Bone Matrix in a Critical Size Femoral Defect Model of the Sprague-Dawley Rat
por: Söhling, Nicolas, et al.
Publicado: (2020) -
From two stages to one: acceleration of the induced membrane (Masquelet) technique using human acellular dermis for the treatment of non-infectious large bone defects
por: Verboket, René Danilo, et al.
Publicado: (2020) -
Characterization of Bone Marrow Mononuclear Cells on Biomaterials for Bone Tissue Engineering In Vitro
por: Henrich, Dirk, et al.
Publicado: (2015) -
Corrigendum to “Characterization of Bone Marrow Mononuclear Cells on Biomaterials for Bone Tissue Engineering In Vitro”
por: Henrich, Dirk, et al.
Publicado: (2015)